Skip Navigation

Open-label, Multicenter, Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of Autologous Anti-Claudin18.2 Chimeric Antigen Receptor T-cell Therapy in Subjects with Advanced Gastric, Pancreatic, or Other Specified Digestive System Cancers

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT04404595

Study #:
STUDY00149186

Start Date:
Jun 22, 2023

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04404595

View Complete Trial Details & Eligibility at ClinicalTrials.gov